{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:43:23Z","timestamp":1771667003780,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.bpg.2016.01.002","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T23:14:12Z","timestamp":1452813252000},"page":"111-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Use of probiotics in prevention and treatment of patients with Clostridium difficile infection"],"prefix":"10.1016","volume":"30","author":[{"given":"Jacob E.","family":"Ollech","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole T.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl V.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Ringel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bpg.2016.01.002_bib1","first-page":"287","article-title":"Clostridium difficile infection","volume":"373","author":"Leffler","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.bpg.2016.01.002_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.bpg.2016.01.002_bib3","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/cid\/ciu955","article-title":"The importance of considering different healthcare settings when estimating the burden of Clostridium difficile","volume":"60","author":"Kuntz","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bpg.2016.01.002_bib4","doi-asserted-by":"crossref","unstructured":"Zimlichman E, Henderson D, Tamir O, et\u00a0al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 173(22):2039-2046. doi:10.1001\/jamainternmed.2013.9763.","DOI":"10.1001\/jamainternmed.2013.9763"},{"issue":"Suppl. 2","key":"10.1016\/j.bpg.2016.01.002_bib5","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1093\/cid\/cis319","article-title":"Current status of Clostridium difficile infection epidemiology","volume":"55","author":"Lessa","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.bpg.2016.01.002_bib6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/cid\/cir643","article-title":"Relapse versus reinfection: surveillance of Clostridium difficile infection","volume":"53","author":"Kamboj","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.bpg.2016.01.002_bib7","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1572-0241.2002.05839.x","article-title":"Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease","volume":"97","author":"McFarland","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.bpg.2016.01.002_bib8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/525047","article-title":"Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea","volume":"197","author":"Chang","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.bpg.2016.01.002_bib9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.bpg.2016.01.002_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.bpg.2016.01.002_bib11","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/cid\/ciu135","article-title":"Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study","volume":"58","author":"Youngster","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.bpg.2016.01.002_bib12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.7326\/0003-4819-157-12-201212180-00563","article-title":"Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis","volume":"157","author":"Johnston","year":"2012","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.bpg.2016.01.002_bib13","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1542\/peds.109.4.678","article-title":"Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis","volume":"109","author":"Van Niel","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.bpg.2016.01.002_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006095.pub3","article-title":"Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children","volume":"5","author":"Goldenberg","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.bpg.2016.01.002_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ajgsup.2012.7","article-title":"Using probiotics in gastrointestinal disorders","volume":"1","author":"Ringel","year":"2012","journal-title":"Am J Gastroenterol Suppl"},{"issue":"12","key":"10.1016\/j.bpg.2016.01.002_bib16","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.3168\/jds.S0022-0302(00)75169-1","article-title":"Characterization and purification of a bacteriocin produced by a potential probiotic culture, Lactobacillus acidophilus 30SC","volume":"83","author":"Oh","year":"2000","journal-title":"J\u00a0Dairy Sci"},{"issue":"18","key":"10.1016\/j.bpg.2016.01.002_bib17","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1073\/pnas.0700440104","article-title":"Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118","volume":"104","author":"Corr","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.bpg.2016.01.002_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1128\/CVI.13.2.219-226.2006","article-title":"The probiotic Bacterium lactobacillus casei induces activation of the gut mucosal immune system through innate immunity","volume":"13","author":"Galdeano","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.bpg.2016.01.002_bib19","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1093\/cid\/civ179","article-title":"Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): characterization, manufacture, mechanisms of action, and quality control of a specific probiotic combination for primary prevention of Clostridium dif","volume":"60","author":"Auclair","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"Pt 7","key":"10.1016\/j.bpg.2016.01.002_bib20","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1099\/jmm.0.47085-0","article-title":"Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains","volume":"56","author":"Rea","year":"2007","journal-title":"J\u00a0Med Microbiol"},{"issue":"1","key":"10.1016\/j.bpg.2016.01.002_bib21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/IAI.67.1.302-307.1999","article-title":"Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa","volume":"67","author":"Castagliuolo","year":"1999","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.bpg.2016.01.002_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.gtc.2005.05.007","article-title":"Physiologic and pathologic interactions of bacteria with gastrointestinal epithelium","volume":"34","author":"Kalliom\u00e4ki","year":"2005","journal-title":"Gastroenterol Clin North Am"},{"issue":"5","key":"10.1016\/j.bpg.2016.01.002_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/mpat.2002.0495","article-title":"Inhibition of in\u00a0vitro cell adherence of Clostridium difficile by Saccharomyces boulardii","volume":"32","author":"Tasteyre","year":"2002","journal-title":"Microb Pathog"},{"issue":"1","key":"10.1016\/j.bpg.2016.01.002_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1757-4749-1-8","article-title":"Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells","volume":"1","author":"Banerjee","year":"2009","journal-title":"Gut Pathog"},{"issue":"2","key":"10.1016\/j.bpg.2016.01.002_bib25","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1053\/j.gastro.2003.11.019","article-title":"Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis","volume":"126","author":"Rachmilewitz","year":"2004","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bpg.2016.01.002_bib26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1023\/A:1010979225018","article-title":"Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes","volume":"21","author":"Gill","year":"2001","journal-title":"J\u00a0Clin Immunol"},{"issue":"4","key":"10.1016\/j.bpg.2016.01.002_bib27","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/IAI.69.4.2762-2765.2001","article-title":"Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice","volume":"69","author":"Qamar","year":"2001","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.bpg.2016.01.002_bib28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/jac\/46.4.603","article-title":"Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil","volume":"46","author":"Orrhage","year":"2000","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.bpg.2016.01.002_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0065-2164(04)54009-1","article-title":"Interactions between Lactobacilli and antibiotic-associated diarrhea","volume":"54","author":"Naaber","year":"2004","journal-title":"Adv Appl Microbiol"},{"issue":"1","key":"10.1016\/j.bpg.2016.01.002_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/AAC.31.1.129","article-title":"Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters","volume":"31","author":"Elmer","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"issue":"9900","key":"10.1016\/j.bpg.2016.01.002_bib31","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(13)61218-0","article-title":"Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"382","author":"Allen","year":"2013","journal-title":"Lancet (London, England)"},{"issue":"9","key":"10.1016\/j.bpg.2016.01.002_bib32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0025-6196(11)62106-X","article-title":"Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial","volume":"76","author":"Thomas","year":"2001","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.bpg.2016.01.002_bib33","first-page":"439","article-title":"Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo","volume":"90","author":"McFarland","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.bpg.2016.01.002_bib34","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0016-5085(89)91613-2","article-title":"Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study","volume":"96","author":"Surawicz","year":"1989","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.bpg.2016.01.002_bib35","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1155\/2007\/720205","article-title":"Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial","volume":"21","author":"Beausoleil","year":"2007","journal-title":"Can J Gastroenterol"},{"issue":"7","key":"10.1016\/j.bpg.2016.01.002_bib36","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/ajg.2010.11","article-title":"Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients","volume":"105","author":"Gao","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"22","key":"10.1016\/j.bpg.2016.01.002_bib37","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.3748\/wjg.v11.i22.3375","article-title":"Different cytokine response of primary colonic epithelial cells to commensal bacteria","volume":"11","author":"Lan","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"18","key":"10.1016\/j.bpg.2016.01.002_bib38","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1001\/jama.2012.3507","article-title":"Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis","volume":"307","author":"Hempel","year":"2012","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.bpg.2016.01.002_bib39","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1572-0241.2006.00465.x","article-title":"Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease","volume":"101","author":"McFarland","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpg.2016.01.002_bib40","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.bpg.2016.01.002_bib41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ajg.2013.4","article-title":"Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections","volume":"108","author":"Surawicz","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"Suppl. 2","key":"10.1016\/j.bpg.2016.01.002_bib42","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1093\/cid\/civ138","article-title":"Prevention of Clostridium difficile infection with probiotics","volume":"60","author":"Evans","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.bpg.2016.01.002_bib43","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/cid\/civ085","article-title":"Risk and safety of probiotics","volume":"60","author":"Doron","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.bpg.2016.01.002_bib44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1517\/14740338.2014.872627","article-title":"A\u00a0systematic review of the safety of probiotics","volume":"13","author":"Didari","year":"2014","journal-title":"Expert Opin Drug Saf"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691816000032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691816000032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:31:35Z","timestamp":1600043495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691816000032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1521691816000032"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2016.01.002","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of probiotics in prevention and treatment of patients with Clostridium difficile infection","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2016.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}